CDH1 and breast carcinoma: We observed that reduction of SNAI2 expression impaired cell migration and increased E-cadherin levels in two fulvestrant-resistant breast cancer cell models, confirming a key role for SNAI2 in the control of cell motility and maintenance of a mesenchymal phenotype in resistant cells.